Training activity information
Details
Produce and evaluate brachytherapy treatment plans for one site other than gynaecological cancers
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- For example: I-125 Plan, HDR prostate plan, HDR Rectum plan, HDR oespohagus/bronchus plan and skin
- Applications of brachytherapy
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What brachytherapy treatment sites other than gynaecological cancers are commonly treated in your department?
- What are the specific anatomical considerations and treatment objectives for your chosen site?
- How do planning considerations differ from gynaecological treatments?
- How will you evaluate the plan to ensure it meets clinical requirements and safety standards?
- What knowledge of different brachytherapy applicators and dose prescription methods for this site do you need?
- What resources or guidance will you consult before attempting to produce the plan?
In action
- During the planning process for this new site, what challenges are you experiencing?
- How does this process differ from gynaecological planning?
- How are you adapting your approach based on the specific anatomy and treatment objectives?
- Are you referring to relevant guidelines or protocols as you plan?
- Are you considering the limitations of the chosen applicator for this site?
- When evaluating the plan, are the dose distributions meeting the clinical objectives and respecting OAR constraints? What specific aspects of the evaluation are requiring more conscious effort?
On action
- What was the specific treatment site for this plan? How did the anatomical considerations for this site differ from gynaecological cases?
- What specific challenges are associated with planning for this particular treatment site? How did the choice of applicator and planning techniques influence the resulting dose distribution? What did you learn about the clinical management and treatment objectives for brachytherapy at this site? How did this experience broaden your understanding of the application of brachytherapy to different anatomical sites?
- What further research or learning will you undertake to develop your expertise in planning for this or other non-gynaecological brachytherapy sites? How will you ensure you consider the unique anatomical and clinical factors for each treatment site in future planning?
Beyond action
- Reflecting on your experience of planning for a non-gynaecological brachytherapy site, have you revisited your initial thoughts and findings?
- How has your understanding of different anatomical sites and their specific treatment requirements evolved?
- How have subsequent experiences broadened your understanding of the application of brachytherapy across different disease sites and influenced your approach to future planning tasks for diverse cancers?
- How have the insights gained from this training activity contributed to your ability to develop and evaluate brachytherapy plans for a wider range of clinical scenarios in your practice since?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 2 |
Outcome
Generate and evaluate brachytherapy treatment plans. |
| # 8 |
Outcome
Practice effectively as part of a multidisciplinary team to provide safe, patient centred radiotherapy treatments. |